Revealing Engagement Patterns Among Hepatic Encephalopathy Patients
ConditionHepatic Encephalopathy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPower Life Sciences Inc.
About this trial
This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in hepatic encephalopathy clinical trials. Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors.
In essence, this trial aims to deepen understanding of the factors influencing participation in hepatic encephalopathy clinical trials. Elevating participation rates could expedite the development of innovative treatments for this challenging condition.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Signed Written Informed Consent
Aged ≥ 18 years old
No prior treatment for hepatic encephalopathy
Disqualifiers
Participant is actively receiving study therapy in another
Inability to provide written informed consent
Women of childbearing potential without a negative pregnancy test; or women who are lactating.
Trial population
Patients with hepatic encephalopathy who are actively considering enrolling in a clinical study, but have not yet completed enrollment and randomization.
Trial design
Design model
Case-crossover
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Rate of patients who decide to join in a hepatic encephalopathy clinical trial
Time frame
3 months2
Number of hepatic encephalopathy patients who remain in clinical trial until completion
Time frame
12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: